Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda's maribavir clears cytomegalovirus infections in phase 3
Fierce Biotech
Fri, 02/12/21 - 11:02 am
Tags:
Takeda, clinical trials, maribavir, CMV
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines
Fierce Biotech
Thu, 02/11/21 - 10:37 am
Tags:
Ensoma, Takeda, CRISPR, gene editing, genomic medicine
Takeda GI veteran Parikh takes charge at 'molecular machines' biotech MOMA Therapeutics
Fierce Biotech
Mon, 02/1/21 - 10:30 am
Tags:
MOMA Therapeutics, Asit Parikh, Takeda
Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag
Endpoints
Thu, 01/28/21 - 10:41 am
Tags:
Takeda, lung cancer, mobocertinib, non-small cell lung cancer
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Tue, 12/15/20 - 08:22 pm
Tags:
Takeda, gene editing, Japan, AnGes, EmendoBio
ASH: Takeda pads case for new leukemia use with 5-year survival data
Fierce Pharma
Tue, 12/8/20 - 12:11 am
Tags:
Takeda, ASH2020, CML, Iclusig
BioCryst takes on Takeda, CSL with FDA approval for Orladeyo, the first pill to prevent HAE attacks
Fierce Pharma
Sat, 12/5/20 - 11:26 pm
Tags:
Biocryst, Orladeyo, HAE, FDA, Takeda, CSL Behring
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Fierce Biotech
Fri, 12/4/20 - 11:00 am
Tags:
Takeda, TAK-620, clinical trials, CMV
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Pharmaceutical Business Review
Wed, 12/2/20 - 10:24 am
Tags:
COVID-19, pandemic, clinical trials, Takeda, Amgen, UCB, COVID R&D Alliance
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
Endpoints
Wed, 11/18/20 - 11:07 pm
Tags:
Pharvaris, HAE, Takeda, CSL
Takeda to partner on patient-centric data with Seqster
Pharmaforum
Thu, 10/29/20 - 10:50 pm
Tags:
Takeda, Seqester, patient data
Takeda Joins Forces with Accenture, AWS to Transform to Cloud-Based Company
BioSpace
Wed, 10/14/20 - 05:33 pm
Tags:
Takeda, Accenture, Amazon Web Services, cloud platforms
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
BioPharma Dive
Sat, 10/10/20 - 11:27 pm
Tags:
clinical trials, plasma, COVID-19, Takeda, CSL
Takeda drops $300M cash to kick off $1B RNAi alliance with Arrowhead, shooting for first-in-class rare disease drug
Endpoints
Thu, 10/8/20 - 10:59 am
Tags:
Takeda, RNAi, Arrowhead Pharmaceuticals, Rare Diseases
Fourth-quarter events to watch for big pharma
EP Vantage
Mon, 09/28/20 - 10:34 pm
Tags:
COVID-19, clinical trials, AstraZeneca, Gilead Sciences, Takeda, GSK, Roche, Alzheimer's disease, Bristol-Myers Squibb, Pfizer, Eli Lilly
Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub
Endpoints
Tue, 09/15/20 - 10:50 am
Tags:
Takeda, Boston, cell therapy, drug manufacturing
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
Pharmafile
Tue, 09/8/20 - 10:33 pm
Tags:
Takeda, Cheplapharm, M&A
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Motley Fool
Sat, 08/29/20 - 11:57 pm
Tags:
Moderna Therapeutics, Japan, Takeda, vaccines, COVID-19
Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?
Endpoints
Tue, 08/25/20 - 09:57 pm
Tags:
Ovid Therapeutics, clinical trials, Takeda, Dravet syndrome, Lennox-Gastaut Syndrome, GW Pharma
Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH
Endpoints
Tue, 08/25/20 - 09:52 pm
Tags:
Takeda, NASH, Engitix, drug development

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.